|
|
Line 85: |
Line 85: |
| ==Ductal carcinoma in situ== | | ==Ductal carcinoma in situ== |
| *Abbreviated ''DCIS''. | | *Abbreviated ''DCIS''. |
| ===General===
| | {{Main|Ductal carcinoma in situ}} |
| *Diagnosis based on nuclear abnormalities ''and/or'' architecture.
| |
| **Low-grade DCIS does '''not''' have a malignant cytology.
| |
| *It is typically picked-up during radiologic screening.
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *Architectural changes:
| |
| **Equal spacing of cells - "cookie cutter" look.
| |
| **Cells line-up along lumen/glandular spaces - form "Roman briges".
| |
| **Architecture suggestive of DCIS - see ''[[Subtypes of DCIS]]''.
| |
| *Nuclear changes:
| |
| **Nuclear enlargement - at least 2-3x size of [[RBC]] - '''key feature'''.
| |
| ***Compared to RBCs to grade DCIS - see ''[[Grading DCIS]]''.
| |
| ****Compare sizes of nuclei if you cannot find RBCs.
| |
| **Nuclear pleomorphism - important feature.
| |
| *+/-Mitoses.
| |
| | |
| Note:
| |
| *Apocrine changes of cytoplasm -- several sets of criteria exist -- any of the following:
| |
| *#Nuclei should be ~4x RBC for low grade, 5x RBC for high grade.<ref>URL: [http://surgpathcriteria.stanford.edu/breast/dcis/apocrinedcis.html http://surgpathcriteria.stanford.edu/breast/dcis/apocrinedcis.html]. Accessed on: 4 August 2011.</ref>
| |
| *#Nuclear enlargement of 3x +/- nucleolar enlargement.<ref name=pmid18171412/>
| |
| *#Multiple nucleoli + nuclear size variation.<ref name=pmid18171412>{{Cite journal | last1 = O'Malley | first1 = FP. | last2 = Bane | first2 = A. | title = An update on apocrine lesions of the breast. | journal = Histopathology | volume = 52 | issue = 1 | pages = 3-10 | month = Jan | year = 2008 | doi = 10.1111/j.1365-2559.2007.02888.x | PMID = 18171412 }}</ref>
| |
| | |
| ====Subtypes of DCIS====
| |
| The subtypes are based on architecture.
| |
| | |
| Note:
| |
| *''Comedonecrosis'' used to be considered a separate subtype. [[Necrosis]] is seen most often in the context of ''solid ductal carcinoma in situ''.
| |
| =====Solid ductal carcinoma in situ=====
| |
| Features:
| |
| *Sheet of cells fills the duct
| |
| *No spaces between cells.
| |
| | |
| <gallery>
| |
| Image:Breast DCIS Solid IntermediateGrade SNP.jpg|Breast - Ductal carcinoma in situ - Solid variant- Intermediate grade - Medium power (SKB)
| |
| Image:Breast DCIS Solid SNP.jpg|Breast - Ductal carcinoma in situ - Solid variant- Intermediate grade - Low power (SKB)
| |
| Image:Breast DCIS Solid PA.JPG|Breast - Ductal carcinoma in situ - Solid variant - Medium power (SKB)
| |
| Image:Breast DCIS Comedonecrotic 2 PA.JPG|Breast - Ductal carcinoma in situ - Solid variant - Comedonecrosis (SKB)
| |
| Image:Breast DCIS Comedonecrosis MP PA.JPG|Breast - Ductal carcinoma in situ - Solid variant - Comedonecrosis (SKB)
| |
| </gallery>
| |
| | |
| DDx:
| |
| *[[LCIS]].
| |
| **May show dyscohesion
| |
| **More monomorphic population of cells
| |
| | |
| =====Cribriform ductal carcinoma in situ=====
| |
| Features:
| |
| *Honeycomb-like appearance: circular holes.
| |
| *"Cookie cutter" appearance/"punched-out" appearance/"Roman bridges" -- cells surround the circular holes.
| |
| | |
| <gallery>
| |
| Image:Breast DCIS Cribriform MP CTR.jpg|Breast - Ductal carcinoma in situ - cribriform varient - medium power (SKB)
| |
| Image:Breast DCIS Cribriform PA.JPG|Breast - Ductal carcinoma in situ - cribriform varient - medium power (SKB)
| |
| </gallery>
| |
| | |
| DDx:
| |
| *[[Collagenous spherulosis]].
| |
| *[[Adenoid cystic carcinoma of the breast]].
| |
| *Invasive cribriform carcinoma of the breast
| |
| | |
| =====Papillary ductal carcinoma in situ=====
| |
| Features:
| |
| *Papillae with fibrovascular cores.
| |
| *Papillae lack a myoepithelial layer
| |
| *Papillae are lined by atypical cells.
| |
| *Papillae within a ductal space lined by myoepithelial cells.
| |
| | |
| <gallery>
| |
| Image:Breast DCIS PapillaryVariant LP PA.JPG|Breast - Ductal carcinoma in situ - Papillary variant - low power (SKB)
| |
| Image:Breast DCIS Papillary PA.JPG|Breast - Ductal carcinoma in situ - Papillary variant - Medium power (SKB)
| |
| </gallery>
| |
| | |
| DDX:
| |
| | |
| *[[Intraductal papilloma]]
| |
| *Ductal carcinoma in situ arising within an intraductal papilloma
| |
| *[[Intracystic papillary breast carcinoma]]
| |
| *[[Invasive papillary breast carcinoma]]
| |
| | |
| =====Micropapillary ductal carcinoma in situ=====
| |
| Features:
| |
| *Small papillae without fibrovascular cores.
| |
| *Have "drum stick" shape.
| |
| | |
| DDx:
| |
| *[[Gynecomastoid hyperplasia]].
| |
| | |
| <gallery>
| |
| Image:Breast DCIS MicropapillaryType MP CTR.jpg|Breast - Ductal carcinoma in situ - micropapillary variant - Medium power - (SKB)
| |
| Image:Breast DCIS Micropapillary SNP.jpg|Breast - Ductal carcinoma in situ - micropapillary variant - High power - (SKB)
| |
| Image:Breast DCIS Apocrine PA.JPG|Breast - Ductal carcinoma in situ - Micropapillary type with apocrine features - High power - (SKB)
| |
| </gallery>
| |
| | |
| ====Grading DCIS====
| |
| Graded 1-3 (low-high)<ref>URL: [http://surgpathcriteria.stanford.edu/breast/dcis/ http://surgpathcriteria.stanford.edu/breast/dcis/]. Accessed on: 4 August 2011.</ref> - compare lesional nuclei to one another.
| |
| *Grade 1:
| |
| **Nuclei 2-3x size of [[RBC]].
| |
| **No necrosis.
| |
| *Grade 2:
| |
| **Nuclei 2-3x size of RBC.
| |
| **+/-[[Necrosis]].
| |
| *Grade 3:
| |
| **Nuclei >3x size of RBC.
| |
| **Necrosis usually present.
| |
| | |
| Notes:
| |
| *It is often hard to find RBCs when you want 'em. DCIS is pleomorphic.
| |
| *If no RBCs are present to compare with compare the nuclei to one another.
| |
| *If you see nuclei >3x larger than their neigbour you're ready to call DCIS Grade 3.
| |
| | |
| ====Size criteria for low-grade DCIS====
| |
| ADH is diagnosed if the lesion is small - specifically:<ref name=Ref_BP168>{{Ref BP|168}}</ref><ref>{{Ref DCHH|258}}</ref>
| |
| # < Two membrane-bound spaces.
| |
| # < 2 mm extent. ‡
| |
| | |
| The treatment is similar; ADH and DCIS are both excised.
| |
| | |
| The differences are:
| |
| *DCIS is cancer, i.e. this has life insurance implications.
| |
| *Radiation treatment - DCIS is irradiated; ADH does ''not'' get radiation.
| |
| | |
| Notes:
| |
| * ‡ 3 mm is used in papillary lesions.{{fact}}
| |
| | |
| ====Micrometastasis in DCIS====
| |
| Micrometastasis in DCIS - not significant.<ref name=pmid14601079>{{Cite journal | last1 = Lara | first1 = JF. | last2 = Young | first2 = SM. | last3 = Velilla | first3 = RE. | last4 = Santoro | first4 = EJ. | last5 = Templeton | first5 = SF. | title = The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. | journal = Cancer | volume = 98 | issue = 10 | pages = 2105-13 | month = Nov | year = 2003 | doi = 10.1002/cncr.11761 | PMID = 14601079 }}</ref><ref name=pmid16569492>{{Cite journal | last1 = Broekhuizen | first1 = LN. | last2 = Wijsman | first2 = JH. | last3 = Peterse | first3 = JL. | last4 = Rutgers | first4 = EJ. | title = The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. | journal = Eur J Surg Oncol | volume = 32 | issue = 5 | pages = 502-6 | month = Jun | year = 2006 | doi = 10.1016/j.ejso.2006.02.006 | PMID = 16569492 }}</ref>
| |
|
| |
|
| =Lobular neoplasia= | | =Lobular neoplasia= |